
|Articles|September 1, 2003
Bioplastique Unique
Author(s)Beth Kapes
Austin, Texas - The macroimplant Bioplastique (Uroplasty BV, Netherlands) biphasic copolymer is one tissue augmentation substance that has brought both benefits and complications to the European market, where it is currently available, Robert A. Ersek, M.D., said.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
The “6-7” Advances for Dermatologists to Look Forward to in 2026
2
Exploring Type 2 Inflammation and Psoriasis Management at Horizons in Advanced Practice
3
Soquelitinib Phase 1 Data Show Sustained Clinical Improvement With Extended Treatment in AD
4
Quoin Targets World’s First Approval for Netherton Syndrome Therapy in Saudi Arabia
5



















